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Abstract
The aim of the research. To expand the knowledge about immunohistochemical changes in female patients with androge-
netic alopecia (AGA) focusing on non-androgenic co-factors of pathogenesis of the disease, as this may serve as a basis for improving 
therapeutic regimens.
Materials and methods. Scalp biopsies of female patients with androgenetic alopecia were examined by immunohistochemi-
cal method. The study included two groups: the main group of 30 female patients aged 22 to 40 years, average age 32.13 ± 5.03 years, 
and the control group that included 20 skin samples from women aged 25–40 years (average age 34.75 ± 4.19 years) who underwent 
autopsies.
Results. It was found that AGA in women is characterized by a number of immunomorphological manifestations: the in-
flammatory infiltrate that consists of immunocompetent T-lymphocytes CD3+, CD4+ and CD8+, macrophages (CD68+); imba-
lance of growth polypeptides VEGF, TGF-β1, EGFR; accumulation of oxidative stress enzymes eNOS and iNOS; accumulation of 
pathological fraction of Collagen IV. 
Conclusions. The data obtained by this study helps to improve the concept of morphogenesis of AGA, and also can become 
a base to improve the standards of treatment of the disease. The pathological triade «oxidative stress-microinflammation- fibrosis» 
should be considered as a possible treatment target, as well as the imbalance of growth peptides.




Hair is an important part of our appearance and social communication. Hair loss could cause 
significant psychological trauma to both female and male patients [1, 2]. This problem is further 
exacerbated by the limited treatment options available, which give only temporary results with 
many chances of side effects [3]. One of the main areas of research in trichology is the study of 
various aspects of AGA.
The aggressive effect of androgens on the hair follicle in androgen-dependent areas of the 
scalp under conditions of genetic predisposition is considered as the main etiopathogenetic mecha-
nism of AGA [4, 5]. However, recent studies show that oxidative stress, micro-inflammation, pre-
mature apoptosis and fibrosis can be considered as non-androgenic cofactors of its development [6].
The role of inflammation in the pathogenesis of AGA was suggested in the 90s of XX centu-
ry [7]. Later, a number of studies reported about the inflammatory infiltration of activated T-cells 
and macrophages and moderate perifollicular fibrosis (which consisted of concentric layers of col-
lagen) found in horizontal sections of scalp biopsies from areas of alopecia in women and men. The 
term «micro-inflammation» was proposed because the process was moderate and different from 
the destructive nature of classical inflammation [8].
Among the reasons that could initiate and participate in the further progression of AGA, 
oxidative stress is also considered. A number of independent studies have demonstrated the effect 
of oxidative stress on the induction of hair follicle cell apoptosis, which leads to an early transition 
to the catagen phase [9, 10]. From an immunological point of view, catagen is a consequence of 
reduced expression of factors responsible for the maintenance of anagen – growth factors IGF-1, 
bFGF, VEGF. Also cytokines (including increased expression of TGFß, IL-1α and TNFα) are 
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involved in this process as inducers of apoptosis. It was noted that the decrease in the proliferative 
activity of dermal papilla cells was associated with changes in cell morphology, including the 
expression of markers of oxidative stress and DNA damage [11].
But so far, the effects of oxidative stress, the inflammatory component and the fibrosis that 
has formed have not been studied properly. The elements of the molecular control of the immune 
system-induced pathological degeneration of the hair follicle by apoptosis-mediated organ death 
have not been studied as well.
Therefore, the aim of the research was to supplement information on the immunohistoche-
mical (IHC) characteristics of the skin in women with AGA. 
2. Materials and methods
The material for the study (main group) were biopsies of the scalp of women with AGA (30 pa-
tients aged 22 to 40 years, average age 32.13 ± 5.03 years), who were monitored in the period from 
2017 to 2020 at the clinical base of the Department of Infectious Diseases and Clinical Immu-
nology of the Medical Faculty of V. N. Karazin Kharkiv National University – «Trichology In-
stitute». The control group included 20 skin samples from women aged 25–40 years (average age 
34.75 ± 4.19 years) who underwent autopsies in the pathology department of Clinical city hospi-
tal No. 17 in Kharkiv. Tissue fragments were performed by standard histological methods, stained 
with hematoxylin and eosin.
During the study, the provisions of the Helsinki Declaration of the World Medical Asso-
ciation, the ethical code of the doctor of Ukraine and informing the patient about the nature of 
the study were strictly observed. All patients involved in the study signed informed consent to 
parti cipate in the study. Protocol No. 2 of the Commission on Biomedical Ethics of V. N. Karazin 
Kharkiv National University of the Ministry of Science of Ukraine dated 13.05.2021.
IHC study was conducted on the basis of the laboratory of the Department of Pathological 
Anatomy of the Kharkiv Medical Academy of Postgraduate Education using antibodies and imaging 
system of Thermo scientific, Germany. The qualitative composition of the inflammatory infiltrate 
was studied using monoclonal antibodies (MCAB) to CD3, CD4 Clone 4B12, CD8 (SP16) (different 
fractions of T-lymphocytes, Ready-to-Use), CD 68 KP1 (macrophage marker, Ready-to-Use). To 
detect oxidative disorders, the expression of markers of nitric oxide metabolism was investigated: 
endothelial nitric oxide synthase (eNOS, Nitric Oxide Synthase, endothelial (eNOS), Rabbit Poly-
clonal Antibody at a dilution of 1:50) and inducible synthase of Nitric oxide (iNOS, Nitric oxide 
Synthase, inducible (iNOS), Rabbit Polyclonal Antibody at a dilution of 1: 100). The nature of angio-
genesis was assessed by the expression of vascular endothelial growth factor (VEGF (VG1)). Epider-
mal growth factor expression was determined using EGFR Polyclonal Antibody (PCAB, titre 1:100). 
As a factor in the induction of the inflammatory process, transforming growth factor (PCAB to 
TGF-β1 (V) Antibody, Ready-to-Use) was studied. Bcl 2 (124), Ready-to-Use, was used as a marker 
of apoptosis. Collagen IV (CIV22) with a titre of 1:50 was detected in the affected scalp areas.
Unmasking heat treatment was performed by boiling the sections in citrate buffer (pH 6.0–7.0). 
UltraVision Quanto Detection Systems HRP Polymer (Thermo scientific, Germany) was used to 
visualize the primary antibodies. DAB (diaminobenzidine) was used as the chromogen.
The results were calculated using the Avtandilov eyepiece [12] in 10 randomly selected 
fields of view at a magnification of ×400. The IHC markers were evaluated on two parameters: 
the degree of distribution and intensity of staining, taking into account the severity of the reaction 
and its location.
The degree of distribution of the marker was taken into account by the percentage of positively 
stained brown organelle cells from the total number of cells in the field of view. To assess the degree 
of colour intensity used a semi-quantitative scale: negative (0) was the reaction in the absence of 
staining of specific cell structures, weak positive (1+) was considered a reaction with weak or focal 
staining from 0 to 30 % of cells, moderate positive (2+) – when sufficient or focal staining of 30–60 % 
of cells, pronounced or diffuse (3+) was considered a reaction when staining 60–90 % of cells.
The complex of morphological studies was performed on a Primo Star microscope (Carl 
Zeiss) using the program AxioCam (ERc 5s).
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Histopathological changes of the scalp in the main group of the study were quite characte-
ristic, which allowed to morphologically confirm the clinical diagnosis. In all cases, the dermis was 
thinned with diffuse hair loss. The presence of hair of different diameters and vellus hair growing 
from miniaturized follicles were noticed. The hair bulb in the area of hair loss, in comparison with 
the control group, were located mainly in the reticular layer of the dermis with a significant reduc-
tion in the hypodermis. Between the non-affected hair follicles, in the area of empty hair bags in 
the area of the upper part of the hair follicles, areas of focal fibrosis of the dermis were found, they 
consisted of concentrically located bundles of connective tissue fibers. The number of sebaceous 
glands was increased compared to the skin of healthy women. In 28 cases out of 30 perivascular-
ly, perifollicularly and between the acinus of the sebaceous glands, lympho-histiocytic infiltrate 
of varying severity was observed.
As a result of IHC examination of skin biopsies found the following. 76.6 % of inflamma-
tory infiltrate cells in the main group were represented by CD3+T-lymphocytes; 40 % of them 
were CD4+T-lymphocytes, and they were observed mainly in the perifollicular zone between the 
acinuses of the sebaceous and sweat glands (Fig. 1). CD8+T-lymphocytes accounted for one third 
of all T-lymphocytes and were found in the connective tissue layers and perivascularly in the der-
mis (28 cases) and hypodermis (2 cases).
Fig. 1. CD4+T-lymphocytes in the inflammatory infiltrate of scalp biopsies of the main  
study group. Reaction from MCAB to CD4 Clone 4B12, ×100
11 % of inflammatory infiltrate cells accounted for CD68+macrophages, which were loca-
ted mainly in the fibrosing fields and in the upper parts of the dermis (Fig. 2).
Fig. 2. Expressed macrophage infiltration in concentrically located fibrosing areas of scalp 









Expression of eNOS in the skin of healthy women was detected only in single macrophages, 
fibroblasts and vascular endotheliocytes, while in the main group it was observed in numerous 
macrophages, fibroblasts, endothelial and muscle layers of vessels, and outer root sheath kera-
tinocytes (Fig. 3, a).
Fig. 3. Expression of eNOS and iNOS in the skin of healthy women: a – Expression of eNOS  
in the outer root sheath. Reaction with PCAB to anti-eNOS; b – Expression of iNOS  
in endothelial cells and fibroblasts. Reaction with PCAB to anti-iNOS, ×100
Inducible nitric oxide synthase iNOS was not determined in the control group, in scalp bi-
opsies with AGA it was expressed in macrophages, vascular endotheliocytes, single epitheliocytes 
of follicles and sebaceous glands and in fibroblasts of the perifollicular fibrosing zone (Fig. 3, b).
The content of VEGF, as well as collagen type 4 was reduced: the reaction with vascular 
growth factor in the vascular endothelium was weak (1+), especially in areas of concentric fibrosis 
with depleted vascularization. The basal membranes of the epidermis, glands, hair follicles and 
blood vessels lost specialized type 4 collagen, and, conversely, its accumulation was noticed in 
atypical perifollicular fibrosing areas (Fig. 4).
Fig. 4. Weak and intermittent expression of type 4 collagen in the basement membranes  
of skin structures of scalp biopsies of the main study group. Reaction from MCAB  
to Collagen IV (CIV22), ×100
The content of TGF-β1 and EGFR was increased in comparison with the control group. 
A strong positive reaction (3+) with PCAB to the transforming growth factor was observed above 
all in the numerous macrophages around the vessels and among the connective tissue strands 
of fibrosis (Fig. 5).
Epidermal growth factor marked both the thinned epidermis and the cells of the root 
sheath (Fig. 6).
 








Fig. 5. Intensive expression of TGF-β1 in skin macrophages of scalp biopsies of the main  
study group. Reaction with PCAB to TGF-β1 Ab-3, ×100
Fig. 6. Intensive expression of EGFR in the epithelial membranes of the hair follicle of the scalp 
biopsies of the main study group. Reaction with PCAB to EGFR Polyclonal Antibody, ×100
The distribution of the antiapoptotic protein Bcl-2 was moderate and, more often, weakly 
expressed (1+), its expression was detected in inflammatory infiltrate cells and correlated with 
increased activity of nitric oxide synthase, especially inducible.
4. Discussion
The AGA process steadily leads to gradual hair loss in compromised areas of the scalp [13, 14]. 
The diagnostic program for AGA includes assessment of clinical manifestations of the disease, 
detection of pathology of ovarian and adrenal glands, pituitary gland, pancreas, thyroid gland, 
liver [15, 16] without detailed consideration of the immunomorphological condition of patients’ skin. 
It is known that the main amount of regulatory proteins and growth factors, such as VEGF, TGF-β1, 
EGFR, is synthesized in the dermal papilla [17]. Fibroblasts, epitheliocytes, endotheliocytes of its 
capillary in the inflammatory process, which was found in 93.3 % of observations of the main 
study group, as well as T-lymphocytes and macrophages of inflammatory infiltrate lose the ability 
to fully produce these control substances [18]. In turn, the matrix of the hair follicle and the adja-
cent dermis begin to accumulate the products of enzymatic decomposition of nitric oxide eNOS 
and iNOS, which can be regarded as a manifestation of oxidative stress [19, 20]. Type 4 collagen 
deposition is observed in the connective tissue fibers of the dermis and bundles of concentric 
perifollicular fibrosis. The complex of immunohistological changes that was identified during the 
study is a sign of pathological imbalance of the perifollicular environment and may be an inducer of 









patients with AGA. A kind of «vicious circle» is formed, which can be broken only by influencing 
each link of morphogenesis.
Immunocorrectives, anti-inflammatory drugs, antioxidants and antifibrosants are not cur-
rently included in the standards of AGA treatment. However, there is an assumption – whether their 
additional use will be a factor that improves patients’ response to therapy.
Study limitations. The study included adult female patients with AGA of verying seve-
rity I-II stages according to the Ludwig scale.
Prospects for further research. The study of immunohistichemical changes in the affec-
ted area of scalp can be used to better understand immunological imbalance in patients with AGA 
and become a basis for improving treatment regimens.
5. Conclusions
AGA is accompanied by a number of immunomorphological changes in the skin, which 
can be detected by performing an IHC reaction. The features of the IHC reaction in the dermis of 
patients with AGA in the form of increased expression of nitric oxide synthases eNOS and iNOS 
indicate a violation of oxidative processes with an imbalance of immunocompetent T-lympho-
cytes CD3+, CD4+ and CD8+, macrophages (CD68+), growth polipeptides VEGF, TGF-β1, EGFR. 
Determination of the pathological fraction of collagen type 4 can be considered as a marker of 
oxidative stress on chronic inflammation, which may be a predictor of further development of peri-
follicular fibrosis and disease progression. The data obtained by us allow to supplement the idea of 
the pathogenesis and morphogenesis of AGA.
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